BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
279.93
+0.93 (0.33%)
At close: Jun 4, 2026, 4:00 PM EDT
279.00
-0.93 (-0.33%)
After-hours: Jun 4, 2026, 7:20 PM EDT
BeOne Medicines AG Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, BeOne Medicines AG stock has a consensus rating of "Strong Buy" and an average price target of $411.91. The average 1-year stock price forecast is 47.15% higher than the current stock price, while the lowest is $333 (+18.96%) and the highest is $501.3 (+79.08%).
Price Target: $411.91 (+47.15%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BeOne Medicines AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 18 | 18 | 18 | 19 | 19 |
| Buy | 7 | 7 | 7 | 7 | 8 | 8 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 26 | 26 | 26 | 26 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $420 | Buy | Maintains | $420 | +50.04% | Jun 3, 2026 |
| Wolfe Research | Wolfe Research | Buy Maintains $340 | Buy | Maintains | $340 | +21.46% | Jun 3, 2026 |
| Barclays | Barclays | Buy Maintains $409 | Buy | Maintains | $409 | +46.11% | Jun 3, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 2, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $424 | Buy | Reiterates | $424 | +51.47% | Jun 2, 2026 |
Financial Forecast
Revenue This Year
45.30B
from 37.37B
Increased by 21.22%
Revenue Next Year
51.92B
from 45.30B
Increased by 14.62%
EPS This Year
3.36
from 17.28
Decreased by -80.56%
EPS Next Year
5.29
from 3.36
Increased by 57.47%
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 47.9B | ||
| Avg | 45.3B | ||
| Low | 43.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.1% | ||
| Avg | 21.2% | ||
| Low | 16.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.78 | ||
| Avg | 3.36 | ||
| Low | 2.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -78.1% | ||
| Avg | -80.6% | ||
| Low | -83.0% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.